Condition: Type 2 Diabetes · Sponsor: University of Birmingham
The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes. The primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 75-90 years of age, living with type 2 diabetes, compared with a non-protein placebo. Participants will consume the whey protein and placebo for 7 days each, before each meal. All participants will consume the placebo and one of two doses of whey protein, in a randomised order.
This description comes directly from the study's public registry record.
Leigh Breen, PhD · (0)1214144109 · l.breen@bham.ac.uk
Marie Korzepa, PhD · m.korzepa@bham.ac.uk
Always discuss trial participation with your own doctor first.
| School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham | Birmingham, West Midlands, United Kingdom | Enrolling By Invitation |
| Heartlands Hospital | Birmingham, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07285811